CIRCULOGENE
Travis has been in diagnostic oncology sales for over 15 years and joined CIRCULOGENE in 2019 from Mayo Clinical Labs where he managed commercial sales. Prior to Mayo, he built the sales teams for Veracyte over an 8 year period growing sales to over $60M. He has also held sales leader roles with Myriad Genetics and Caris Life Sciences. Travis holds a MBA from UNC, Chapel Hill and has a Bachelor’s Degree from the University of Alaska where he had a basketball scholarship.
This person is not in any offices
CIRCULOGENE
Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence.